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Abstract
Background -Allergic bronchopulmonary aspergillosis is a serious complication of cystic fibrosis and may be difficult to diagnose. The aim of this study was to define the usefulness ofmeasuring total IgE compared with other major criteria in the diagnosis of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Methods -A retrospective analysis was carried out of the case records of 160 children attending a tertiary referral paediatric cystic fibrosis clinic. Results -Sixteen children had a total IgE level above 500 IU/ml. Eleven children had six or more other major criteria and were considered to have allergic bronchopulmonary aspergillosis. These clinically with a fall in total IgE concomitant with radiological improvement. This provided further evidence to support the diagnosis but, since some of our patients had also been given intravenous antibiotics, some diagnostic uncertainty remained. Using our diagnostic criteria, however, the prevalence of ABPA in our clinic population (12/160, 7 5%) was similar to other published series.'-3
Supporting evidence for the diagnosis may come from measurements of RAST and precipitins to Aspergillusfumigatus. All the patients in group 1 had a positive RAST, implying that a negative RAST excludes or casts strong doubts on the diagnosis. However, all the patients in group 2 also had a positive RAST, reducing its predictive value. Precipitins were positive in 1 1 out of 12 of the children in group 1, but in none of the patients in group 2 in whom it was sought. Thus positive precipitins, particularly if they were previously negative, may be a stronger pointer to the diagnosis of ABPA in combination with a high or rapidly rising IgE.
The children in group 2 with a raised IgE level had four or fewer of the criteria for ABPA; none was treated with prednisolone. Patients 13 and 16 were completely stable between the two measurements of IgE, and the increases were attributed to known atopic status. Of note was the absence of a fourfold rise in IgE level. Patient 14 had a steep rise in IgE with no clinical or radiological features of ABPA. He received no treatment and a year later his IgE level had reverted to below 500 IU/ml with no change in clinical status. We have no explanation for this result. Patient 15 came to the clinic with minimally increased respiratory symptoms and had a segmental consolidation on the chest radiograph. He was treated with oral antibiotics and, by the time the IgE result was to hand, he had recovered clinically and radiologically. He was given no further treatment and subsequently his IgE level reverted to normal. Patient 17 had a raised IgE level at routine annual assessment. His chest radiograph was normal which does not exclude the diagnosis'4 but his krypton ventilation scan revealed that the right upper lobe was not ventilated. He was treated with oral antibiotics but no other additional medication and his IgE levels fell to normal. A subsequent ventilation scan was also normal. It is possible that these two patients had subclinical episodes of ABPA which resolved spontaneously, a sequence which has been described before in cystic fibrosis.315 However, simple mucus plugging or infection cannot be excluded.
Aspergillusfumigatus has the capacity to cause numerous pulmonary problems including asthma, ABPA, mycetoma, and invasive disease. It has the capacity to grow at body temperature, and hence within the airways of patients.9 The consequence may be the exposure of patients to a heavy antigen load, generating an intense humoral immune response."6-18 Additionally Aspergillus fumigatus produces at least one proteinase which may damage bronchial epithelium.'9 This intense response may set up cycles of further obstruction, inflammation, and lung damage. In common with others we found that ABPA is not rare in the cystic fibrosis population,' often requires high doses of prednisolone for control, and frequently relapses. Relapse of ABPA was associated in group 1 with a further abrupt rise in IgE level (figure), confirming the diagnostic utility of this measurement. These findings accord with the results of others,'520 although less stringent criteria have been proposed. Greenberger20 suggested that a doubling of total IgE was sufficient to signal the onset of ABPA, rather than the fourfold rise we propose. Presumably the timing of the blood samples will determine the extent of the rise, and further work is needed to delineate the minimum criteria for a truly significant rise in IgE levels.
Clearly there is no one diagnostic test that will be 100% sensitive and specific for ABPA. We would not advocate treating all patients with a raised level of IgE with prednisolone, since this would appear to have been unnecessary in five of the 17 children in this study. However, taken in context with the clinical picture, the presence of other major criteria and, in particular, if there is a fourfold or greater rise in titre, we believe that measurement of total IgE is an important diagnostic pointer towards ABPA. This measurement has the further merit of being easily and rapidly available. Many of the more sophisticated tests are bedevilled by differences in the quality of the Aspergillus fumigatus antigens used for .esting in different laboratories.2' The presence of precipitins to Aspergillusfumigatus, at least as measured with Bencard standard antigens 1 and 2, is a further useful pointer to the diagnosis. Indeed, the diagnostic criteria could be simplified to the presence of symptoms, appropriate radiographic changes, a fourfold rise in total IgE, and the presence of precipitins.
In conclusion, we suggest that measurement of total IgE levels, where possible in combination with precipitins and RAST to Aspergillus fumigatus, is an important part of the examination of any child with cystic fibrosis who has an acute respiratory deterioration. 
